ArticleMolecules (Basel, Switzerland)2025
Encapsulation of a Highly Acid-Stable Dicyano-Bodipy in Zr-Based Metal-Organic Frameworks with Increased Fluorescence Lifetime and Quantum Yield Within the Solid Solution Concept.
Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Synthesis of BODIPY@MOFs as Hybrid Materials for Emerging Applications: A Review.Molecules (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
In this work, we have synthesized a more acid-stable variant of the classic chromophore difluoro-Bodipy by substituting the difluoro ligands at boron with cyano groups. This dicyano-Bodipy variant allowed the in situ incorporation during the MOF formation under acidic conditions and was investigated for the first time as dye@MOF composites using both post-synthetic and in situ incorporation into the zirconium-based metal-organic frameworks (MOFs) UiO-66, MOF-808, DUT-67, and MIP-206. The successful incorporation of dicyano-Bodipy was confirmed by PXRD, N
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.